This trial studies the effects of cannabis use on solid tumor cancer patients undergoing treatment for their cancer. Studying the effects of different types of cannabis and cannabinoids (the different constituent parts of cannabis) on cancer-related symptoms, quality of life, and cognition when used by patients undergoing treatment for cancer, may help doctors inform patient choices and future harm reduction efforts.
Additional locations may be listed on ClinicalTrials.gov for NCT03617692.
See trial information on ClinicalTrials.gov for a list of participating sites.
PRIMARY OBJECTIVE:
I. To demonstrate the number of contacts necessary to enroll 30 eligible patients and demonstrate reasonable compliance with study procedures within twenty-four months of active recruiting.
OUTLINE:
Patients use their marijuana (cannabis) product of choice orally (PO) for 2 weeks then complete questionnaires, memory and thinking assessments at baseline then at 1 and 2 hours after each cannabis use.
After completion of study, patients are followed up at 1 month.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationUCHealth University of Colorado Hospital
Principal InvestigatorAngela Bryan
